Detection of EGFR Mutations, ALK, and ROS1 Rearrangements in Cytological Specimens: An Institutional Experience

被引：0
|
作者：
Naous, Rana [1 ]
Zhang, Shengle [1 ]
Khurana, Kamal K. [1 ]
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
434
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [41] Coexistence of driver aberrations in NSCLC patients including ALK/RET/ROS1 rearrangements.
    Bien-Willner, Gabriel Alejandro
    Yang, Dong
    Xia, Dianren
    Wang, Jixin
    Indiviglio, Sandra
    Renard, Jamie
    Miles, George
    Mambo, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
    A. S. Mansfield
    Z. Wei
    R. Mehra
    A. T. Shaw
    C. H. Lieu
    P. M. Forde
    A. E. Drilon
    E. P. Mitchell
    J. J. Wright
    N. Takebe
    E. Sharon
    D. Hovelson
    S. Tomlins
    J. Zeng
    K. Poorman
    N. Malik
    R. J. Gray
    S. Li
    L. M. McShane
    L. V. Rubinstein
    D. Patton
    P. M. Williams
    S. R. Hamilton
    B. A. Conley
    C. L. Arteaga
    L. N. Harris
    P. J. O’Dwyer
    A. P. Chen
    K. T. Flaherty
    npj Precision Oncology, 6
  • [43] EGFR gene mutations and ALK rearrangements in lung carcinomas
    Shin, Mi Kyung
    Kim, Jeong Won
    Hong, Min Eui
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S62 - S62
  • [44] Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
    Mansfield, A. S.
    Wei, Z.
    Mehra, R.
    Shaw, A. T.
    Lieu, C. H.
    Forde, P. M.
    Drilon, A. E.
    Mitchell, E. P.
    Wright, J. J.
    Takebe, N.
    Sharon, E.
    Hovelson, D.
    Tomlins, S.
    Zeng, J.
    Poorman, K.
    Malik, N.
    Gray, R. J.
    Li, S.
    McShane, L. M.
    Rubinstein, L., V
    Patton, D.
    Williams, P. M.
    Hamilton, S. R.
    Conley, B. A.
    Arteaga, C. L.
    Harris, L. N.
    O'Dwyer, P. J.
    Chen, A. P.
    Flaherty, K. T.
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [45] Molecular Testing of EGFR, EGFR Resistance Mutation, ALK and ROS1 Achieved by EBUS-TBNA in Chile
    Fernandez-Bussy, Sebastian
    Labarca, Gonzalo
    Pires, Yumay
    Caviedes, Ivan
    Burotto, Mauricio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (03): : 172 - 174
  • [46] Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibit ROS1/TRK/ALK Solvent-Front Mutations
    Drilon, Alexander
    Ou, Sai-Hong Ignatius
    Cho, Byoung Chul
    Kim, Dong-Wan
    Lees, Jeeyun
    Lin, Jessica J.
    Zhu, Viola W.
    Ahns, Myung-Ju
    Camidge, D. Ross
    Nguyen, Judy
    Zhai, Dayong
    Deng, Wei
    Huang, Zhongdong
    Rogers, Evan
    Liu, Juliet
    Whitten, Jeff
    Lim, John K.
    Stopatschinskaja, Shanna
    Hyman, David M.
    Doebele, Robert C.
    Cui, J. Jean
    Shaw, Alice T.
    CANCER DISCOVERY, 2018, 8 (10) : 1227 - 1236
  • [47] ROS1: Rearrangements und AnalytikROS1: rearrangements and analytics
    Udo Siebolts
    Sabine Merkelbach-Bruse
    Die Pathologie, 2023, 44 (1) : 50 - 52
  • [48] Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma
    Grenier, Karl
    Riviere, Jean-Baptiste
    Bencheikh, Bouchra Ouled Amar
    Corredor, Andrea Liliam Gomez
    Shieh, Benjamin Christopher
    Wang, Hangjun
    Fiset, Pierre Olivier
    Camilleri-Broet, Sophie
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (07):
  • [49] ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1
    Fielder, Timothy
    Butler, Jordan
    Tierney, Geraldine
    Holmes, Mikaela
    Lam, Ki Yuk
    Satgunaseelan, Laveniya
    Colebatch, Andrew J.
    Mahar, Annabelle
    Gupta, Ruta
    O'Toole, Sandra
    Cooper, Wendy A.
    PATHOLOGY, 2022, 54 (04) : 399 - 403
  • [50] Correlating ROS1 Protein Expression With ROS1 Fusions, Amplifications, and Mutations
    Huang, Richard S. P.
    Gottberg-Williams, Amanda
    Vang, Panhia
    Yang, Shoua
    Britt, Nicholas
    Kaur, Jaspreet
    Haberberger, James
    Danziger, Natalie
    Owens, Clarence
    Beckloff, Sara E.
    Ross, Jeffrey S.
    Ramkissoon, Shakti H.
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (02):
12345